Drug Profile
Research programme: Gram-negative infection therapeutics - Shionogi
Alternative Names: AGN-BLLatest Information Update: 24 Aug 2022
Price :
$50
*
At a glance
- Originator Shionogi
- Class Antibacterials; Cephems; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Gram-negative infections